Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson’s Disease
- 2 September 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Neurobiology
- Vol. 54 (7), 5400-5413
- https://doi.org/10.1007/s12035-016-0027-8
Abstract
Bone marrow-derived neural stem cells (NSCs) are ideal cells for cellular therapy because of their therapeutic potential for repairing and regenerating damaged neurons. However, the optimization of implanted cells and the improvement of microenvironment in the central nervous system (CNS) are still two critical elements for enhancing therapeutic effect. In the current study, we observed the combined therapeutic effect of NSCs with fasudil in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease (PD) mouse model and explored the possible cellular and molecular mechanisms. The results clearly show that combined treatment of NSCs with fasudil further improves motor capacity of PD mice, thus exerting double effect in treating MPTP-PD. The combined intervention more effectively protected dopaminergic (DA) neurons from loss in the substantia nigra pars compacta (SNpc), which may be associated with the increased number and survival of transplanted NSCs in the brain. Compared with the treatment of fasudil or NSCs alone, the combined intervention more effectively inhibited the activation and aggregation of microglia and astrocytes, displayed stronger anti-inflammatory and antioxidant effects, induced more neurotrophic factor NT-3, and affected the dynamic homeostasis of NMDA and AMPA receptors in MPTP-PD mice. Our study demonstrates that intranasal administration of NSCs, followed by fasudil administration, is a promising cell-based therapy for neuronal lesions.Keywords
Funding Information
- National Natural Science Foundation of China (81501198, 81272163)
- Department of Science and Technology, Shanxi Province of China (2013081058)
This publication has 77 references indexed in Scilit:
- AMPA Receptor Phosphorylation and Synaptic Colocalization on Motor Neurons Drive Maladaptive Plasticity below Complete Spinal Cord Injuryeneuro, 2015
- Neurotoxicity effects of atrazine-induced SH-SY5Y human dopaminergic neuroblastoma cells via microglial activationMolecular BioSystems, 2015
- Neural stem cell transplantation promotes behavioral recovery in a photothrombosis stroke model.2015
- Effects of hypothermia combined with neural stem cell transplantation on recovery of neurological function in rats with spinal cord injuryMolecular Medicine Reports, 2014
- Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseBrain, 2012
- Treatment of rat spinal cord injury with a Rho-kinase inhibitor and bone marrow stromal cell transplantationBrain Research, 2009
- Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesionsBrain Research Bulletin, 2009
- Neuronal responses to myelin are mediated by rho kinaseJournal of Neurochemistry, 2006
- Transient Focal Cerebral Ischemia Down-Regulates Glutamate Transporters GLT-1 and EAAC1 Expression in Rat BrainNeurochemical Research, 2001
- Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of MicrogliaJournal of Neuroscience, 2000